Hippocratic AI, a generative AI company, is partnering with Israel-based Sheba Medical Center to unite its AI agent technology and Sheba’s ARC (accelerate, redesign, collaborate) Innovation Center.
Hippocratic AI will join the ARC ecosystem, a global network comprising leading hospitals, researchers and innovation organizations.
The ARC Innovation Center is a multidisciplinary model that unites clinicians, entrepreneurs and researchers.
Via the partnership, Hippocratic AI will integrate its generative AI agents to support "non-diagnostic, patient-facing roles into Sheba’s live clinical and research environments."
Initial areas of collaboration include triage and patient intake.
"Partnering with Sheba is an important step forward in realizing our mission to deliver safe, effective, high-quality generative AI healthcare at scale," said Munjal Shah, cofounder and CEO of Hippocratic AI.
"Sheba’s strong reputation for clinical excellence and its innovation ecosystem at ARC make it the perfect partner to help us deliver transformative AI tools to providers and patients worldwide."
THE LARGER TREND
Earlier this month, tax, audit and advisory firm KPMG announced a collaboration with Hippocratic AI to utilize its agents in addressing global workforce shortages.
The aim was for Hippocratic AI's genAI agents to free up provider time by using conversational agents designed to interact with humans naturally and intuitively.
The company stated that its agents comprehend, process and respond to human conversations in a contextually relevant and human-like manner.
In May, Hippocratic AI partnered with EUCALIA, a healthcare transformation company, to launch the first Japanese-language genAI healthcare agent for non-diagnostic, patient-facing clinical tasks.
The partnership marked Hippocratic AI's entry into the Japanese market.
EUCALIA provides management and operational support to healthcare professionals, including medical care, as well as the management and optimization of hospital operations.
This year, the Japanese genAI healthcare agent is being introduced, aiming to support clinicians by taking on time-consuming but important non-diagnostic patient-facing tasks, including appointment scheduling, follow-up outreach, chronic care check-ins and medication adherence support.
Hippocratic AI aims to boost clinician workflow efficiency, enhance high-quality patient engagement and improve patient outcomes.
In April, Burjeel Holdings, a United Arab Emirates-based healthcare services provider, and Hippocratic AI announced a strategic partnership to transform healthcare delivery.
Burjeel Holdings operates in parts of the Middle East and North Africa. Hippocratic AI and Burjeel announced their alliance during the Abu Dhabi Global Healthcare Week, which took place last week.
Through the alliance, Hippocratic AI's genAI healthcare agents will be constructed for "patient-facing non-diagnostic clinical tasks," distributed across Burjeel Holdings' healthcare facilities and physiotherapy clinics in the UAE and Oman.
Additionally, Hippocratic AI's capabilities will enable Burjeel Holdings to transform patient engagement and provide personalized and empathetic clinical conversations with patients.
